Showing results (251-260 of 302) with videos related to
Sort By:
Pageof 31
Transplant Immunology|December 24, 1997
Interleukin-12 p40 m-RNA expression in human kidney allograft biopsiesA M de Mattos, M M Meyer, D J Norman, et al.Experimental Nephrology|January 1, 1997
Prednisone alters the histopathology of chronic cyclosporine nephropathyI E Stillman, J English, E A Burdmann, et al.Transplantation Proceedings|September 20, 2017
Renal Cell Carcinoma in Renal Transplantation: The Case for SurveillanceW M Bennett, E L Simonich, A M Garre, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 1, 1989
Mesangiocapillary glomerulonephritis type II (dense-deposit disease): clinical features of progressive diseaseW M Bennett, R G Fassett, R G Walker, et al.The Journal of Infectious Diseases|April 1, 1984
Nephrotoxicity of the constituents of the gentamicin complexS J Kohlhepp, M O Loveless, P W Kohnen, et al.Annals of Internal Medicine|August 1, 1980
Drug therapy in renal failure: dosing guidelines for adults. Part II: sedatives, hypnotics, and tranquilizers; cardiovascular, antihypertensive, and diuretic agents; miscellaneous agentsW M Bennett, R S Muther, R A Parker, et al.Annals of Internal Medicine|July 1, 1980
Drug therapy in renal failure: dosing guidelines for adults. Part I: Antimicrobial agents, analgesicsW M Bennett, R S Muther, R A Parker, et al.Antimicrobial Agents and Chemotherapy|November 1, 1992
Duration of the protective effect of polyaspartic acid on experimental gentamicin nephrotoxicityS K Swan, D N Gilbert, S J Kohlhepp, et al.Clinical Pharmacology and Therapeutics|May 1, 1988
Vancomycin pharmacokinetics, renal handling, and nonrenal clearances in normal human subjectsT A Golper, H M Noonan, L Elzinga, et al.Antimicrobial Agents and Chemotherapy|June 1, 1985
Attenuation of experimental tobramycin nephrotoxicity by ticarcillinJ English, D N Gilbert, S Kohlhepp, et al.Pageof 31